Quantitative proteomics of cerebrospinal fluid from patients with Alzheimer disease.
暂无分享,去创建一个
Jing Zhang | Jimmy Eng | R. Aebersold | T. Montine | J. Eng | D. Goodlett | J. Kaye | J. Quinn | E. Peskind | E. Yi | Jing Zhang | C. Pan | Yong Zhou | Thomas J Montine | Elaine Peskind | Eugene Yi | Jeffrey A Kaye | Joseph F Quinn | Yong-Chun Zhou | Qin Wang | Catherine Pan | Dave R Goodlett | Qin Wang | Ruedi H Aebersold
[1] S. Folstein,et al. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.
[2] E. Lander,et al. A molecular signature of metastasis in primary solid tumors , 2003, Nature Genetics.
[3] D. Hochstrasser,et al. A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer's disease , 2003, Proteomics.
[4] Jing Zhang,et al. Quantitative proteomic analysis of age-related changes in human cerebrospinal fluid , 2005, Neurobiology of Aging.
[5] J. Trojanowski,et al. Biological markers for therapeutic trials in Alzheimer’s disease Proceedings of the biological markers working group; NIA initiative on neuroimaging in Alzheimer’s disease , 2003, Neurobiology of Aging.
[6] E. Petricoin,et al. Use of proteomic patterns in serum to identify ovarian cancer , 2002, The Lancet.
[7] J. Morris,et al. Clinical Dementia Rating: A Reliable and Valid Diagnostic and Staging Measure for Dementia of the Alzheimer Type , 1997, International Psychogeriatrics.
[8] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease , 1984, Neurology.
[9] R. Aebersold,et al. Automated statistical analysis of protein abundance ratios from data generated by stable-isotope dilution and tandem mass spectrometry. , 2003, Analytical chemistry.
[10] S. Gygi,et al. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags , 1999, Nature Biotechnology.
[11] R. Aebersold,et al. Approaching complete peroxisome characterization by gas‐phase fractionation , 2002, Electrophoresis.
[12] R. Aebersold,et al. Mass spectrometry in proteomics. , 2001, Chemical reviews.
[13] R. Reitan. Validity of the Trail Making Test as an Indicator of Organic Brain Damage , 1958 .